Puma Biotechnology (PBYI) Interest & Investment Income (2012 - 2026)
Puma Biotechnology (PBYI) reported Interest & Investment Income of $1.0 million for Q1 2026, down 8.99% on a YoY basis from $1.1 million in Q1 2025, and up 2.56% quarter-over-quarter from $977000.0 in Q4 2025.
Puma Biotechnology (PBYI) Interest & Investment Income (2012 - 2026) Analysis & Trends
Puma Biotechnology has reported Interest & Investment Income for 15 years, with the latest figure at $1.0 million in Q1 2026.
- For the quarter ending Q1 2026, Interest & Investment Income fell 8.99% year-over-year to $1.0 million; the trailing twelve-month figure through Mar 2026 stood at $4.0 million (down 18.01% YoY), and the FY2025 full-year result was $4.1 million, down 13.67% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $1.0 million, up from $977000.0 in the prior quarter.
- The five-year high for Interest & Investment Income was $1.3 million in Q3 2024, with the low at $13000.0 in Q1 2022.
- Historically, Interest & Investment Income has averaged $777764.7 across 5 years, with a median of $956000.0 in 2025.
- Annual changes were most pronounced in 2022 — Interest & Investment Income slumped 46.28% — and 2023, when it jumped 4030.77%.
- Puma Biotechnology's Interest & Investment Income stood at $519000.0 in 2022, then surged by 38.54% to $719000.0 in 2023, then soared by 70.51% to $1.2 million in 2024, then slipped by 20.31% to $977000.0 in 2025, then gained by 2.56% to $1.0 million in 2026.
- The last three Interest & Investment Income figures came in at $1.0 million (Q1 2026), $977000.0 (Q4 2025), and $1.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 597,319.59 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 305,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -14.79 Mn |
| 10 | Puma Biotechnology | 384.39 Mn | 282.84 Mn | 34.39 Mn | 1.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.00 Mn |
| Dec 31, 2025 | 977,000.00 |
| Sep 30, 2025 | 1.04 Mn |
| Jun 30, 2025 | 956,000.00 |
| Mar 31, 2025 | 1.10 Mn |
| Dec 31, 2024 | 1.23 Mn |
| Sep 30, 2024 | 1.28 Mn |
| Jun 30, 2024 | 1.24 Mn |
| Mar 31, 2024 | 972,000.00 |
| Dec 31, 2023 | 719,000.00 |
| Sep 30, 2023 | 689,000.00 |
| Jun 30, 2023 | 660,000.00 |
| Mar 31, 2023 | 537,000.00 |
| Dec 31, 2022 | 519,000.00 |
| Sep 30, 2022 | 216,000.00 |
| Jun 30, 2022 | 65,000.00 |
| Mar 31, 2022 | 13,000.00 |
| Dec 31, 2021 | 13,000.00 |
| Sep 30, 2021 | 13,000.00 |
| Jun 30, 2021 | 121,000.00 |